Introduction
Much concern has been raised about adverse health effects on vanadium and its compounds to which workers exposed in various work environments, such as smelting and refining, welding and cutting of vanadium-rich steel alloy, cleaning and repair of oil-fired boilers and catalysis of chemical productions 1, 2) . It was known that oil-fired boilers in ships and stations, oil refineries and catalysis-recycling processes released soot and fly ash containing high concentrations of vanadium pentoxice (V 2 O 5 ) 1, 3, 4) . An acute phase of adverse health effects by inhalation of vanadium compounds dust was characterized by irritation of nose with bleeding, rhinitis, and eyes with lacrimation, conjunctivitis, and of the upper respiratory tract, sore throat, persistent violent coughs, audible wheezing in the chest, bronchitis, and bronchopneumonia [4] [5] [6] . The acute phase, recognized by animal experiments of vanadium compounds exposed to the respiratory system, was characterized by tracheitis, bronchitis, bronchopneumonia, emphysema, pulmonary edema and hemorrhagic inflammation [4] [5] [6] . Several experimental evidence 7-10, 12, 13) implicate that the lung toxicity of metallic fumes and dust is affected not only by degree of exposure but also by size, solubility and oxidized states of those materials. The present study was intended to clarify acute histopathological effects of intratracheally instilled V 2 O 5 powder on the lungs of rat and to examine their correlations with physicochemical properties of the powder as causative factors of the histopathological lung lesions. Gross and histopathological changes in the lungs and growth rates of V 2 O 5 -administered rats were examined as toxicity indices together with solubility of the V 2 O 5 powder in artificial biological liquid so-called "Gamble's solution" and distilled water, size distribution and oxidized states of the V 2 O 5 powder.
Materials and Methods

Vanadium powder used
V 2 O 5 powder of a reagent grade used in the present study was purchased from Wako Pure Chemicals Ltd (Japan).
Size distribution and oxidized states of vanadium powder used
Size distribution of V 2 O 5 powder was determined by a previously described method 11) with an analytical transmission electron microscope (H-8000, Hitachi Co., Japan). In order to determine the particle size of V 2 O 5 powder, many photographs were taken by the transmission electron microscope (TEM) at a magnitude of × 500. Images of these TEM negatives were optically enlarged 5 times on the prints on which each particle was measured its size manually using an optical magnifier of 10 times. Therefore, particle size measurements were done totally at × 25,000.
The purity of V 2 O 5 powder was examined by a solid-liquid extraction column method 15) . The powder was dissolved in a warm 1 M H 2 SO 4 solution and then adjusted to pH 4 with 2 M sodium acetate solution. The dissolved sample was applied to a preconditioned anion exchange column for removing V (V) as oxoacid anion. The concentration of V (IV) in the solution from the column was determined with an inductively coupled plasma atomic emission spectrometer (ICP-AES, Jobin-Yvon JY-138 Ultrace, Instruments S.A. Jobin-Yvon Division, France). The concentration of V (V) was calculated on the proportionality of concentrations between V (IV) and total vanadium.
Animals
Male rats of the Sprague-Dawley strain were purchased from Charles River Japan at the age of 4 weeks and housed in wire-meshed cages (5 rats/cage) in animal facility. The animal room was maintained at a temperature of 24 ± 1°C, a relative humidity of 55 ± 5% and an automatic lighting schedule of a 12-hr light (8:00-20:00)/12-hr dark (20:00-8:00) cycle. The rats were allowed free access to autoclaved food pellets (CE-2, CLEA Japan) and UV-sterilized tap water.
Administration of vanadium powder
The V 2 O 5 powder was suspended and sonicated in a physiological saline at concentrations of 13.0, 3.0 and 0.88 mg V 2 O 5 /kg body weight. Each 8-week-old rat weighing (325.4 ± 16.1 g) was administered intratracheally with the V 2 O 5 powder-suspended solutions of 0.5 ml at doses of 13.0, 3.0 and 0.88 mg V 2 O 5 /kg body weight. The control group of rats received saline only. The dose levels of V 2 O 5 powder were determined by our preliminary experiment which demonstrated that the administration of 96 and 48 mg V 2 O 5 powder/kg caused death of all rats tested within 30 minutes after dosing. The method for the intratracheal instillation of V 2 O 5 powder-suspended solution was described previously 12) .
Histopathological preparation and evaluation of the affected lung
Five rats each of the V 2 O 5 powder-dosed groups were sacrificed in 3 days, 1, 2 and 4 weeks, and three rats each of the control groups were sacrificed in 1 and 4 weeks after the intratracheal instillation. All the rats were prepared for pathological examination by the method described previously 12) . Histopathological changes in the lungs of V 2 O 5 powderadministered rats were examined under a microscope for 9 items of lesion types, and each of the lesion types was scored on a scale of increasing severity from 0 to 4 as described previously 12) .
Solubility of vanadium powder in distilled water and
Gamble's solution V 2 O 5 powder of 50 mg was poured into a 15 mL test tube. Then, purified water (obtained by a WF-20 water-purifying system, Yamato, Japan) or Gamble's solution 14) of 5 mL was added into the test tube. The purified water was prepared by 3 times distillation of distilled water. Gamble's solution was prepared according to the composition reported by Scholze and Conradt 14) . The V 2 O 5 powder-suspended solutions were kept shaking in a water bath of 37°C during the time periods of 1, 3, 10, 30, 100, 300 and 1440 minutes. Then, each suspended solution was decanted into a 25 mL disposable syringe (Terumo, Japan) attached with a syringe-driven filter unit (Millipore Millex-HV, hydrophilic PVDF, 25 mmφ, pore size 0.45 µm, Millipore, USA). A 2 mL of 1M HNO 3 was added with a 0.2 mL portion of the filtered sample solution as a stabilizer. The purified water-based sample solution was added 0.2 mL of Gamble's solution for adjustment of viscosity, and finally diluted to total volume of 20 mL by purified water. Gamble's solution-based sample solution was diluted by purified water to total volume of 20 mL. The vanadium concentrations were measured by inductively coupled plasma atomic emission spectrometer (ICP-AES, Jobin Yvon JY-138 Ultrace, Horiba, Japan) observing wavelength of 309.311 nm. 
Results
Growth rate
Gross finding
Fourteen out of twenty 13.0 mg/kg-dosed rats (70%) died within the first 4 days. The post-mortem examination indicated exudation of serous or hemorrhagic effusion from nose and foamy liquid from trachea. Some of those rats exhibited retention of serous pleural fluid in the thoracic cavity, marked diffuse coloration with dark red and brown induration of the pulmonary hilus. The six survived rats exhibited atelectasis on the pulmonary hilus, clater-like induration on the surface of the lobes and petechial hemorrhage surrounding in those lesions. The administration of 3.0 mg/kg caused mild brown induration on day 3 after the intratracheal instillation, but those lesions became slighter in weeks 2 to 4. The administration of 0.88 mg/kg-dosed rats showed slightly focal sporadic dark-red patches over the entire lung surface and a light red coloration of the pulmonary hilus on day 3. Thereafter, there were no observable changes in the lungs.
Histopathological examinations of the lungs
Histopathological changes induced by a single intratracheal instillation of 13.0 mg V 2 O 5 powder/kg could be characterized by severe acute exudative inflammations: desquamation and degeneration of swelled broncho-bronchiolar epithelium, hyperplasia of the goblet cell, diffuse hemorrhage, effusions of fibrin and pulmonary edema. It was also remarkable that mobilization and destruction of macrophages and foamy cells, and infiltration of inflammatory cells in the alveolar space. Table 1 summarizes histopathological changes in the lungs of rats after administration with 3.0 mg V 2 O 5 powder/kg. The 3.0 mg/kg-dosed rats, showed marked desquamation, degeneration, hyperplasia and swelling of the bronchobronchial epithelium, increased mucous secretion with bronchitis and bronchiolitis. Leakage of plasma, pulmonary edema, hemorrhage and perivascular edema, were also observed together with infiltration of inflammatory cells as well as mobilization and destruction of macrophages and foamy cells (Fig. 2-A, B) . These lesions were pronounced for 4 weeks except desquamation in the bronchiole and hemorrhage and effusions of fibrin in the alveolus. The microscopic observations for the lungs of 13.0 mg V 2 O 5 powder/kg-dosed rats revealed that the V 2 O 5 particles were not seen around the bronchioles, alveolar ducts and alveoli where macrophages and other inflammatory cells were abundantly present.
The administration of 0.88 mg V 2 O 5 powder/kg showed similar of histopathological changes as in the 3.0 mg/kg instillation. However, the lesions were milder and disappeared in shorter time than those induced by the 3.0 mg/kg instillation except for swelling and goblet cell metaplasia, mobilization of macrophages and foamy cells (Fig. 2-C) . In 4 weeks those lung lesions were recovered except for very slight accumulation of foamy cells in the alveolar space. Figure 3 shows solubility of V 2 O 5 powder in purified water and Gamble's solution. A marked difference in solubility of V 2 O 5 powder was found between these solutions. The concentration of vanadium ions dissolved in purified water reached a plateau level of 300 ppm (v/v) within the first 5-hr period, whereas the concentration in Gamble's solution increased exponentially to 1900 ppm (w/w) during the first 5-hr period, and thereafter still increased up to 2800 ppm after 24 hr.
Solubility, size distribution and oxidized states of vanadium
The particle size of V 2 O 5 powder used in the present study was measured as 0.31 µm in geometric mean diameter with geometric standard deviation σ g =2. 19 . It was confirmed by electron microscopic observation that the used powder was composed of the primary particles of less than 1.0 µm in diameter and that those particles were not coagulated but well dispersed in water. Chemical analysis of the V 2 O 5 powder showed that the particles contained vanadium (V) pentoxide of greater than 99.8% (w/w) accompanying with less than 0.2% of vanadium (IV) tetraoxide.
Discussion
It was found in the present study that intratracheal instilled very fine V 2 O 5 particles in the lungs of rats produced dosedependent histopathological changes which were characterized by exudative inflammations, injury of alveolar macrophage, and swelling and mucous degeneration of the broncho-bronchiolar epithelium. The growth rates of the V 2 O 5 powder-administered rats were also found to be retarded dose-dependently. It has been reported that affection of inhaled metal particles and fumes on the lungs related not only by the degree of exposure but their size distribution, solubility and oxidized states 7-10, 12, 13) . The findings reported by Zhang et al. 8) and Kyono et al. 9) indicate that higher lung toxicity of ultrafine cobalt powder is related to smaller size and higher solubility of the particles. Serita et al. 10) reported that ultrafine metallic nickel was ten times more soluble in Gamble's solution than in purified water. Toya et al. 12) reported that very fine particles of Ni 2 O 3 were more toxic than ordinary particles of NiO. In the present study, dosedependent characteristics were found for the V 2 O 5 powder in relation to those histopathological lung lesions: It was found by TEM observation and chemical analysis by ICP-AES that the V 2 O 5 powder was composed of very fine and well dispersed particles in water, and consisted mostly pure of vanadium pentoxide (V 2 O 5 ) particles. It is noteworthy that the solubility of V 2 O 5 powder in an artificial biological fluid of Gamble's solution was found to be much higher than that in purified water. It has been published so far that the vanadium aerosol induces histopathological lesions in the lungs. Roschin 16, 17) demonstrated nosebleed, hemorrhage of alveolar space, perivascular edema, pulmonary edema and desquamative bronchitis in the rat after inhalation to an aerosol of V 2 O 5 at a concentration of 3-5 mg/m 3 for 2 hours in every other day for 3 months and to an aerosol of V 2 O 5 at a concentration of 10-30 mg/m 3 for 1 hour in every day for 4 months. The powder sample they used 16, 17) was obtained by heating vanadium pentoxide in the flame of a Volta arc and by 19) observed desquamation of small type epithelium due to edema, diffuse edema in alveolar wall and infiltration of inflammatory cells in alveolar space after short-term inhalation exposure of rats to aerosol of 3.21 mgV 2 O 5 /m 3 . Therefore, good coincidence of the histopathological lesions in the present study with those reported so far [16] [17] [18] [19] can be taken to indicate that there is no essential difference in the histopathological lesion between the water-soluble condensed aerosol of V 2 O 5 and the V 2 O 5 powder used in the present study.
It has been considered that the V 2 O 5 particles are not soluble in the lung, because solubility of V 2 O 5 in purified water was 0.08% 20) . In the present study, however, the V 2 O 5 powder was found to be much more soluble in an artificial biological fluid (Gamble's solution) than in distilled water. The fine particles was not observed microscopically in the lungs of rats on day 3 after intratracheal instillation of V 2 O 5 powder in the present study, while in the previous studies the fine nickel and chromium particles were seen on the same day after intratracheal instillation of those powders 12, 13) . This difference is due to higher solubility of the V 2 O 5 powder in the lung liquid. Thus, the histopathological evidences such as focal edema, hemorrhage, leak of blood plasma and fibrin in the alveolus and perivascular edema found in the present study suggest that the endothelial damage and subsequent leakage of plasma would be caused by toxicity of dissolved vanadium. Therefore, it can be inferred that the lung lesions observed histopathologically are induced not only by the V 2 O 5 particles but also by vanadium ions dissolved from the particles in the extra-and intracellular lung fluid.
Dreher et al. 21) demonstrated that the supernatant solution of residual oil fly ash (ROFA) containing Fe, Ni, V, Ca and Mg produced the same extent of acute inflammatory lung injuries as the ROFA suspension per se when the two different state of samples were intratracheally-instilled in the rat. Kodavanti et al. 22) demonstrated that pulmonary responses of rats to ROFA differ by virtue of water-soluble metals and that the neutrophilic response to ROFA exposure was positively correlated with the water-leachable content of V. They suggested that soluble transition metals of ROFA play a key role in the pulmonary injury 21, 22) . Carter et al. 23) also reported that in vitro exposure of human bronchial epithelial cells to vanadium-containing ROFA, but not iron-or nickel-, mimicked the effects of intact ROFA which produced significant amounts of IL-8, IL-6, and TNF, as well as mRNAs coding for those cytokines. These results reported by Dreher et al. 21) , Kodavanti et al. 22) and Carter et al. 23) seem to be in favor of our inference that the V 2 O 5 powderinduced histopathological lesions are caused not only by the V 2 O 5 particles per se but also by the ions. Waters et al. 24) reported that cell viability after 20-hr in vitro exposure of rabbit alveolar macrophages was reduced by 50% at 13 µg V/ml as V 2 O 5 , 21 µg V/ml as V 2 O 3 , and 33 µg V/ml as VO 2 , and that the cytotoxicity decreased in the order of V 2 O 5 >V 2 O 3 >VO 2 in coincidence with the order of solubility in the medium. Any mechanism underlying the V 2 O 5 powder-induced lung lesions is not clear at present. Zychlinski et al. 25) demonstrated that in the presence of NADPH vanadate is reduced to vanadyl by lung microsomes with concomitant oxidation of NAD(P)H. They also proposed a mechanism underlying vanadium-induced pulmonary toxicity that vanadium (V) undergoes one-electron redox cycling in rat lung biomembranes, and reoxidation of vanadium (IV) initiates lipid peroxidation under an aerobic condition. It is, however, interesting to speculate on a plausible mechanism under which the fine V 2 O 5 powder is taken up by phagocytosis of alveolar macrophages and other cells, leading to production of various cytokines such as inflammatory cytokines 26) , chemotactic proteins 27) , interferon 28) and to reactive oxygen species 29) and resulting in the acute inflammatory lung injury.
Further study will be needed to clarify soluble chemical species as a causative factor of the histopathological lung lesions induced by administration of V 2 O 5 powder.
